Today stock market will be red..PM resigning.

Other people keep getting orders....

KUALA LUMPUR: Pharmaniaga Bhd’s unit has inked an agreement with the government to supply an additional six million doses of the Covid-19 vaccine.

Very hard to cari makan these days...

Has Pharma gotten the renewal for medicine supply contract from Government yet?

Bro MadCow, The roticanai man will protect the GLC companies at all cost. Be careful....

Means prices would be capped...no more high prices for private vaccines. Good for the rakyat.

https://www.msn.com/en-my/news/national/pac-wants-private-market-sinovac-price-kept-reasonable/ar-AAMBL8A?ocid=msedgntp

Profits is one thing. Able to collect debts is another especially at these pandemic times.

I believe the booster shots will not be the same as the present ones. It would be new type to counter Delta or Lambda more effectively. No point using same one when the recipe is not effective.

I was at MITI Pikas Industrial Program at SACC Shah Alam yesterday, thousands of foreign workers all queuing up for vaccinations. No need private vaccine at all for these workers.

After 1/8/21, people including undocumented foreigners from Selangor / KL can walk in without registration for vasin at all centers.
Sarawak already confirm no need to buy anymore vaccine.
https://www.theedgemarkets.com/article/vaccines-provided-under-pick-are-enough-sarawak-%E2%80%94-dr-sim

Yes, private market will be there. Just only who can run fastest.It will be vaccine price war..so far only Sinovac & Sinopharm approved for 3-17 yrs. Pfizer for 12 - 17 yrs. Moderna will be next coming in.

There will be plenty of private vaccine brands to choose from in future. The fight to get distributorships and approvals is over. It is now about getting the sales and making profits. Which company has the best and fastest sales network to supply to the public will win the race.

The art of deception and projection...

This operator never change tactics...hehe.

Is this Hayat Vax WHO approved? I know this is Sinopharm grade but it is not the same as WHO approved Sinopharm. Europe recognise all WHO approved vaccines. So any implications on this issue? So you buy from Duo Pharma or Kanger?

So when will this HAYAT VAX be approved by NPRA?

Now no more Sinopharm Wuhan Changde. Hehehe...
New manufacturer even though same product formula (maybe not exact same) also need NPRA approval. I really salute these people. Don't even have the courtesy of announcing what happen to the original agreement.

No lar...I still got 20k shares...leftovers from those days at 0.155. I already written them off...see which day when my mood is right to CL. Already given up on this counter, not going to buy RI.

0.65 still ok. RI is 0.60...for those who bought at 0.055. Hehe..

Until today, there is one big question not answered. There are 2 type of Sinopharm vaccine. One from Bejing which is WHO approved and another one from Wuhan which is not known if it is approved or not.

Big question is which Sinopharm Kanger signed up for? Or rather the China company which is handling Kanger case is in charge of Wuhan or Beijing Sinopharm vaccine.

Anyone know this answer?

MZM2511, I am referring to PearlCapital on the MOU with Sabah which indeed is a MOU and not an agreement.

Zuellig Pharma and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced a new partnership with Zuellig Pharma’s division, ZP Therapeutics, to supply the COVID-19 Vaccine Moderna in Southeast Asia, Hong Kong, Macau and Taiwan.

https://www.zuelligpharma.com/news/news-zuellig-pharma-partners-with-moderna-to-supply-moderna-s-covid-19-vaccine-in-asia

MZM2511....Please do not (repeat) do not look at the newspaper reports.

Follow Bursa announcements: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3092107

Kanger is NOT the sole distributor, it never was at all.

1. MOU is not an agreement. It is just a letter to state understandings.
2. Are you sure 10k vaccine were received? Without NPRA approval, it cannot be used or for trial.

Actually I read this already last month. Hehehe...

Khairy said private companies right now are unable to provide COVID-19 vaccines on the private market due to lack of vaccine supply, however, he added that several private companies will soon be authorised to bring in vaccine supplies directly from China. This would include the Sinopharm COVID-19 vaccine which is expected to be registered soon.

He said he is in talks with the Ministry of Health to ensure that the private vaccine market can take off by August. He added that he has also instructed a GLC pharmaceutical company to start talking to the Chinese suppliers to import vaccines for the private market.

Khairy said “If you want to go fast, you pay-lah” and this would help to accelerate COVID-19 vaccinations in Malaysia.

SETTLE...obviously NOT. Hahahaha...

I tried to ask hard questions last time...and the answers are very obvious...hhehe

Hi 18K...I am good.TQ

Kenyataan Akhbar KPK 16 Julai 2021 – Keputusan Mesyuarat Pihak Berkuasa Kawalan Dadah Kali Ke-361 Berkenaan Pendaftaran Vaksin COVID-19

Kementerian Kesihatan Kesihatan (KKM) ingin memaklumkan bahawa Mesyuarat Pihak Berkuasa Kawalan Dadah (PBKD) kali ke-361 telah bersidang pada hari ini, 16 Julai 2021.
Mesyuarat telah bersetuju memberikan kelulusan pendaftaran bersyarat untuk kegunaan semasa bencana bagi dua (2) produk vaksin COVID-19 iaitu:

1. COVILO Suspension for Injection COVID-19 Vaccine (Vero Cell), Inactivated
Pemegang pendaftaran: Duopharma (M) Sdn. Bhd.
Pengilang: Beijing Institute of Biological Products Co. Ltd. (BIBP), China
COVILO merupakan vaksin yang dibangunkan oleh China National Biotec Group Company Limited (CNBG), Sinopharm, yang juga dikenali sebagai vaksin COVID-19 Sinopharm.

2. Janssen COVID-19 Vaccine Suspension for Injection
Pemegang pendaftaran: Johnson & Johnson Sdn. Bhd.
Pengilang: Janssen Pharmaceutica N.V., Belgium

Kelulusan pendaftaran bersyarat ini memerlukan maklumat kualiti, keselamatan dan keberkesanan produk vaksin tersebut dipantau dan dinilai berdasarkan data-data terkini dari semasa ke semasa. Ia bagi memastikan perbandingan manfaat-risiko (benefit over risk) bagi produk-produk vaksin tersebut kekal positif.

KKM akan sentiasa mempertingkatkan tahap kesihatan awam dalam memerangi wabak COVID-19 melalui perolehan bekalan vaksin yang telah dinilai daripada aspek kualiti, keselamatan dan keberkesanan oleh Bahagian Regulatori Farmasi Negara (NPRA) dan diluluskan oleh PBKD. Kerajaan juga komited untuk memastikan penduduk dewasa Malaysia mencapai imuniti kelompok (herd immunity) selaras dengan sasaran Program Imunisasi COVID-19 Kebangsaan (PICK).

TAN SRI DATO’ SERI DR. NOOR HISHAM BIN ABDULLAH
Ketua Pengarah Kesihatan Malaysia
16 Julai 2021

Zuellig Pharma and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced a new partnership with Zuellig Pharma’s division, ZP Therapeutics, to supply the COVID-19 Vaccine Moderna in Southeast Asia, Hong Kong, Macau and Taiwan.

“Our collaboration with Moderna to supply the COVID-19 Vaccine Moderna in Asia reaffirms Zuellig Pharma’s commitment to help fight the global pandemic. We are committed to making healthcare accessible through innovation, commercial excellence and robust in-market capabilities that will not only improve healthcare but will expand patient access. We are drawing upon our expertise, resources, and extensive distribution network to support governments and where allowed private healthcare institutions across the region in implementing end-to-end vaccination programs. As importantly, we are working closely with governments to help them plan for the security of their vaccine supply,” said John Graham, Chief Executive Officer, Zuellig Pharma.

Thailand get Sinopharm deliveries. Malaysia sampai bila?

https://www.bangkokpost.com/thailand/general/2134767/thousands-to-get-sinopharm-vaccine

So what are the results from EGM? Passed all?

it is very simple...got Sinopharm or no Sinopharm imported into Malaysia. Very simple yes or no. Kalau takde, say takde. If need funds and need to raise RI, say company no more money. Need to raise funds.Habis cerita.
All other stories, MOUs, Press release, possibilities is not important anymore.

Kanger cannot keep issuing statements on this or that, hoping share prices would go up then they disappear. No follow up. They cannot simply say Sinopharm is expected to be delivered in May, approval by NPRA is in process but no concrete announcements. Talk is cheap for them but for some bilis investors, it is hard earned, sweat money.

MZM2511, Jangan risau. I not saying you are a promoter. I can see you write on past reports, though got mistakes I point out like not Sole Distributor or not Main Contractor. And you admit the mistake. No problems.

I am just hoping Kanger Management will read all these frustrations and their performance so far is not trusting. They have to improve if they want investor confidence.

I also hope Sinopharm get approved by NPRA...my Kanger and Kstar shares can get unloaded..but it is just talk so far. Dah 7 months already since Dec 2020.

Bingo....If Sinopharm was truly just registered with NPRA.
The big question is "IF" which means don't know, unsure, not confirmed.

If the Sinopharm was truly just registered with NPRA, the process of approval should be more shorter in time compared with the vaccine candidate which not been approved by WHO yet.

What for approved by WHO. Malaysia not approved ma...how to make money?

Question: Kanger say will receive 10,000 doses Sinopharm in May 2021. So received already?

My fren tell me this..very funny.

Why company keep issuing shares, PP and RI? To get more money into the company.

Why no borrow from banks? If banks want to lend, you think need to do so much trouble like PP or RI? And make like MOUs to sound like company is going to do well. But many people like fairy tale ma.

Why bank don't want to lend? If company keep losing money, how to lend? Banks also don't want the shares. Banks all same. If you got money, they lend you money. If you no money, they all run away.

So now you know la....

This Kanger very smart and deceptive but not wrong on announcements. They know people read only little bit and not the details. So have to be extra careful.

It is a collaborative agreement, not a joint venture.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3135288


4.3 VCSB shall continue to be the contractor of the Project, wherein Kanger Ventures shall be
responsible for the project management aspect of the Project.

4.4 Kanger Ventures shall:
a) Coordinate the construction work of the Project;
b) Management of subcontractors appointed by VCSB;
c) to afford all assistance and cooperation to VCSB to enable completion of the Project;
d) to assist in procuring financing of the Project; and
e) to manage payment to subcontractors.

There is a big difference between construction business and construction management services. One is actual physical work while construction management services is to provide managers, supervisors, quantity surveyors. Totally different in profits and revenue.
So which is Kanger doing? Read and understand carefully.

MZM2511...all my comments are there for you to read. Feel free to check them out from August 2020.

18K, ingat tak...PP wayang tahun lepas? Semua kena tipu.

No need to goreng vaccine anymore. We all know long ago.

Kanger no need Sinopharm. It is bonus only. Kanger is buluh business.

Who is the Chairman of Kanger..the answer is there.

MZM2511 @Noobie123. I am sorry and oppoligize for the referred statement that is not true as stated. I already retracted my statement. Sorry.

Thank you. Pls do not misunderstand I am here to badmouth. I asked critical and very hard questions only. In the past, I had invested quite a lot in Kanger much more than an average Joe. I don't mind losing or making but business sense must prevail.

MZM2511 @Noobie123. It's up to you to analyze it. You have to many reasoning to look for.
The company's MOU/agreement will be a real businesses when the incoming EGM approve it.

For me, the referred MOU/Agreement is not a SCAM as you said before

Show me the comment that I called this MOU/agreement a SCAM or if I used the word SCAM and I will eat my words, otherwise apologise and retract your statement.